Treatment of Hairy Cell Leukemia in its Second Half-Century April 26, 2010
10 Center Dr, Building 1 – Wilson Hall
Bethesda, Maryland 20814
Bethesda, Maryland 20814
David Fitzgerald will present an abstract on the topic of enhancing immunotoxin cell-killing activity via combination therapy with ABT-737.
Robert Kreitman, MD will present on the topic of recombinant immunotoxins and other therapies for relapsed/refractory HCL.
Added by MedImmune on April 22, 2010